Under new ownership and leadership, the company reasserts its mission of providing affordable, innovative therapies for canine joint disease and cancer.
Top headlines of the week: State VMAs endorse Feline Fix by Five Months, rabies update, drug DISCO, and The Vet Blast Podcast with guest Steve Dale.
A look at the One Health initiative that is stepping beyond science to generate more treatments more quickly for canine and human cancer.
Immunotherapy — using an individual’s own immune system to fight disease — is one of the fastest-growing areas in both human and veterinary research. Here’s the latest.
Apocrine gland anal sac adenocarcinoma is an aggressive cancer that might be better harnessed with targeted chemotherapeutic agents. A recent study evaluated the efficacy of toceranib in treating this tumor, and assessed prognostic factors.